User:aoifekjpa529918

Bavituximab, also TRWH-783, represents a innovative immunotherapy strategy targeting phosphatidylserine (PS). PS is usually an cellular lipid present within cell membranes; however, it's often

https://www.targetmol.com/compound/bavituximab